Orthofix Medical Inc   (OFIX)
Other Ticker:  
Price: $14.8900 $0.02 0.134%
Day's High: $14.95 Week Perf: -1.39 %
Day's Low: $ 14.55 30 Day Perf: 13.66 %
Volume (M): 192 52 Wk High: $ 21.60
Volume (M$): $ 2,853 52 Wk Avg: $14.85
Open: $14.92 52 Wk Low: $9.58

 Market Capitalization (Millions $) 558
 Shares Outstanding (Millions) 37
 Employees 1,000
 Revenues (TTM) (Millions $) 668
 Net Income (TTM) (Millions $) -136
 Cash Flow (TTM) (Millions $) -18
 Capital Exp. (TTM) (Millions $) 53

Orthofix Medical Inc
Orthofix Medical Inc. is a global medical device company that focuses on developing and distributing innovative solutions for musculoskeletal conditions. The company was founded in 1987 and is headquartered in Lewisville, Texas, USA. Its products are used in the areas of spine, trauma, sports medicine, extremities, and biologics.

Orthofix Medical's products and services are divided into two segments - Orthofix Spine and Orthofix Extremities. In total, the company has more than 600 employees and operates in over 70 countries, with global headquarters in Lewisville, Texas, and regional offices in Europe, Latin America, and Asia.

Orthofix Spine offers a wide range of spinal implant products, including spinal fusion systems for cervical, thoracolumbar, and lumbar spine surgeries. The company also offers vertebral compression fracture treatment, cervical disc replacement, and osteotomy systems for spinal deformity correction.

Orthofix Extremities focuses on medical devices for the upper and lower extremities, including external fixation systems, internal fixation systems, joint replacement and reconstruction, and biologic solutions for bone and tissue reconstruction. The company offers a full range of products for hand, wrist, elbow, foot, and ankle surgeries, as well as non-surgical treatments.

Orthofix Medical is committed to advancing the field of musculoskeletal medicine through research, innovation, and education. The company has invested heavily in research and development, and has established collaborative partnerships with leading physicians to develop new products and surgical techniques.

Orthofix Medical has received numerous awards and accolades for its products and services, including recognition by Forbes as one of America's best small companies, and recognition by the Orthopaedic Research and Education Foundation for its innovative research initiatives.

Overall, Orthofix Medical is a leading player in the global medical device industry, providing innovative solutions for musculoskeletal conditions and improving patients' quality of life.

   Company Address: 3451 Plano Parkway Lewisville 75056 TX
   Company Phone Number: 937-2000   Stock Exchange / Ticker: NASDAQ OFIX


Stock Performances by Major Competitors

5 Days Decrease / Increase
• View Complete Report


Orthofix Medical Inc. Reports Exceptional Surge in Net Sales, Reinforcing Market Dominance and Accelerating Growth Strategies.

Published Tue, Jan 9 2024 1:00 PM UTC

Orthofix Medical Inc., a leading global spine and orthopedics company, has recently revealed their preliminary unaudited net sales results for the fourth quarter and full-year 2023. The company showcased outstanding growth, achieving a significant increase in net sales on both reported and constant currency bases. This article will outline the facts and assess the impact of ...

Management Changes

Orthofix Medical Inc. Appoints Massimo Calafiore as New President and CEO, Achieves Record Revenue Growth

Published Tue, Nov 28 2023 12:00 PM UTC

Orthofix Medical Inc., a leading global spine and orthopedics company, has announced that Massimo Calafiore will be joining the company as its new President and Chief Executive Officer. Currently serving as the CEO of LimaCorporate S.p.A., a global orthopedics company, Calafiore is expected to assume his new role at Orthofix in early 2024, following the completion of Li...

Orthofix Medical Inc

Orthofix Medical Inc Exhibits Unusual Conduct during Third Quarter of 2023, Raising Concerns within the Industry

Orthofix Medical Inc Reports Widened Deficit in Q3 2023, but Shows Strong Revenue Growth
Lewisville, Texas - Orthofix Medical Inc (NASDAQ:OFIX) recently released its financial results for the quarter ending September 30, 2023. The medical equipment and supplies company reported a widened deficit of $-0.77 per share, compared to $-0.53 per share in the same period the previous year. However, there was positive news as well: the company's earnings per share (EPS) improved from $-1.07 to $-0.77 per share over the previous reporting period.
One of the standout figures was the significant rise in revenue, which increased by an impressive 61.201% to $183.76 million from $114.00 million in the corresponding reporting period a year prior. Sequentially, however, revenue decreased marginally by -1.494% from $186.55 million.

Product Service News

Orthofix Establishes a Waves of Success in Spinal Fusion with WaveForm L Interbody System

Published Mon, Nov 6 2023 12:00 PM UTC

In an exciting development for the field of spinal fusion, Orthofix Medical Inc. has announced the full commercial launch of its groundbreaking WaveForm L Lateral Lumbar Interbody System. This advanced medical device, designed for lateral lumbar interbody fusion (LLIF) procedures, boasts a unique 3D-printed structure that prioritizes strength and stability, creatin...

Orthofix Medical Inc

Orthofix Medical Inc Delivers Complex Financial Performance in Q2 2023: Losses Up, Revenue Growth Presents Opportunities for Shareholders

The stock market is always buzzing with news and updates that can lead investors to make informed decisions. In the second quarter of 2023, Orthofix Medical Inc (OFIX) experienced both losses and revenue growth, showcasing a complex situation for shareholders. This article will delve into the quarterly report and provide some interesting insights into OFIX's financial performance.
Financial Performance in Q2 2023:
During the second quarter of 2023, OFIX reported losses of $-1.07 per share, a significant increase compared to $0.12 a year ago. However, there is a silver lining as the earnings per share improved from $-1.71 in the previous quarter, indicating some progress.


Orthofix Medical Inc's Segments
• View Complete Report


About us


CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com